Abraham Bwalhuma Muhindo
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Abraham Bwalhuma Muhindo has a total of 9 co-authors. Here are the top co-authors by number of shared publications:
- Adamu Almustapha Aliero
Kebbi State University of Science and Technology, Aliero
3 shared publications - Emmanuel Eilu
Kampala International University
2 shared publications - Festo Mwebaze Syalhasha
Clarke International University
2 shared publications - Ibrahim Ntulume
Department of Pharmacology and Therapeutics, School of Medicine, Health and Life Sciences, King Ceasor University
2 shared publications - Joe Mutebi
Computing Bushenyi Western Region Kampala International University - Western Campus
2 shared publications - Martin Odoki
Kampala International University
2 shared publications
Latest Publications
- Open Access
- 1 December 2025
- Published by Institute of Advanced Engineering and Science in International Journal of Public Health Science (IJPHS)
- Vol. 14 (4) , 1666
Antimicrobial resistance profiles of methicillin resistant coagulase negative Staphylococcus at a reference laboratory in Sierra Leone: implications for infection control
Methicillin-resistant CoNS (MR-CoNS) are increasingly recognized as significant nosocomial pathogens. Sierra Leone lacks data on the prevalence and antibiotic-resistance patterns of these bacteria, which hinders a cross-sectoral approach to tackling antimicrobial resistance as well as regional and global health surveillance. We report on clinical multidrug-resistant MR-CoNS from Freetown, Sierra Leone, West Africa, as emerging pathogens. This study aimed to explore the prevalence and antimicrobial resistance profiles of MR-CoNS isolated from clinical samples in Freetown, Sierra Leone. A cross-sectional study was conducted at the reference laboratory from January 2025 to June 2025. Clinical samples submitted to the microbiology department were screened for Staphylococcus species, and isolates identified as coagulase-negative Staphylococci (CoNS) using standard microbiological techniques. Methicillin resistance in all isolates was tested with a 30 μg cefoxitin disc and further confirmed through an automated Scenker XK Microbial ID and AST system by measuring the minimum inhibitory concentration (MIC) with oxacillin. Antibiotic susceptibility profiles were determined using the Scenker XK Microbial ID/AST system following the Clinical and Laboratory Standards Institute (CLSI) guidelines, and data were analysed using SPSS ver 16. Findings from our study show a prevalence of 18.2% of MR-CoNS with Staphylococcus schleiferi, (26.9%) predominant. Linezolid, vancomycin, and teicoplanin exhibited 100% activity against all the MR-CoNS isolated. However, there was co-and multidrug resistance exhibited to commonly known antibiotics gentamycin (75-100%), levofloxacin (80-100%), clarithromycin (87-100%), including resistance to newer antibiotics as daptomycin (33-50%).
- 1 December 2025
- Published by Institute of Advanced Engineering and Science in International Journal of Public Health Science (IJPHS)
- Vol. 14 (4) , 1666
Open AccessAntimicrobial resistance profiles of methicillin resistant coagulase negative Staphylococcus at a reference laboratory in Sierra Leone: implications for infection control
Methicillin-resistant CoNS (MR-CoNS) are increasingly recognized as significant nosocomial pathogens. Sierra Leone lacks data on the prevalence and antibiotic-resistance patterns of these bacteria, which hinders a cross-sectoral approach to tackling antimicrobial resistance as well as regional and global health surveillance. We report on clinical multidrug-resistant MR-CoNS from Freetown, Sierra Leone, West Africa, as emerging pathogens. This study aimed to explore the prevalence and antimicrobial resistance profiles of MR-CoNS isolated from clinical samples in Freetown, Sierra Leone. A cross-sectional study was conducted at the reference laboratory from January 2025 to June 2025. Clinical samples submitted to the microbiology department were screened for Staphylococcus species, and isolates identified as coagulase-negative Staphylococci (CoNS) using standard microbiological techniques. Methicillin resistance in all isolates was tested with a 30 μg cefoxitin disc and further confirmed through an automated Scenker XK Microbial ID and AST system by measuring the minimum inhibitory concentration (MIC) with oxacillin. Antibiotic susceptibility profiles were determined using the Scenker XK Microbial ID/AST system following the Clinical and Laboratory Standards Institute (CLSI) guidelines, and data were analysed using SPSS ver 16. Findings from our study show a prevalence of 18.2% of MR-CoNS with Staphylococcus schleiferi, (26.9%) predominant. Linezolid, vancomycin, and teicoplanin exhibited 100% activity against all the MR-CoNS isolated. However, there was co-and multidrug resistance exhibited to commonly known antibiotics gentamycin (75-100%), levofloxacin (80-100%), clarithromycin (87-100%), including resistance to newer antibiotics as daptomycin (33-50%).
- Open Access
- 30 May 2024
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 7 (2) , 187-197
Review of Antifungal Resistance in West Africa
Knowledge of local and regional antimicrobial resistance (AMR) is important for clinical decision-making. However, surveillance capacity for fungal infections let alone antifungal resistance is lacking throughout West Africa, and current antifungal resistance data are sparse. We sought to address this gap by summarizing all available high-quality data on antifungal resistance in West Africa. We searched the PubMed database, African Journals Online archives, and free web searches in October and December 2023 using the terms "antifungal resistance" and "West Africa" to find articles published from 2010 onwards. Only 11 articles were included in our analysis most of which were cross-sectional and descriptive in design; relatively high levels of antifungal resistance (AFR) to commonly used antifungals were reported including (24-75%) resistance to fluconazole and ketoconazole, two of the most frequently-prescribed antifungals in this region. There is a high level of resistance to griseofulvin, ketoconazole, cotrimoxazole, and fluconazole among dermatophyte infections (80-100%) with 100% resistance to amphotericin B, ketoconazole, and fluconazole reported by the invasive fungal disease-causing pathogen Cryptococcus neoformans. Resistance to commonly used anti-fungal drugs is prevalent; raising concern that these drugs may no longer be useful for treating moderate or severe fungal infections in West Africa hence calling for countries to promote acceptance of antimicrobial stewardship as a programmatic strategy not just focused on bacterial resistance but also fungal resistance including pharmacy management, laboratory complete mycological investigations and dissemination of standard fungal susceptibility profiles.
- 30 May 2024
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 7 (2) , 187-197
Open AccessReview of Antifungal Resistance in West Africa
Knowledge of local and regional antimicrobial resistance (AMR) is important for clinical decision-making. However, surveillance capacity for fungal infections let alone antifungal resistance is lacking throughout West Africa, and current antifungal resistance data are sparse. We sought to address this gap by summarizing all available high-quality data on antifungal resistance in West Africa. We searched the PubMed database, African Journals Online archives, and free web searches in October and December 2023 using the terms "antifungal resistance" and "West Africa" to find articles published from 2010 onwards. Only 11 articles were included in our analysis most of which were cross-sectional and descriptive in design; relatively high levels of antifungal resistance (AFR) to commonly used antifungals were reported including (24-75%) resistance to fluconazole and ketoconazole, two of the most frequently-prescribed antifungals in this region. There is a high level of resistance to griseofulvin, ketoconazole, cotrimoxazole, and fluconazole among dermatophyte infections (80-100%) with 100% resistance to amphotericin B, ketoconazole, and fluconazole reported by the invasive fungal disease-causing pathogen Cryptococcus neoformans. Resistance to commonly used anti-fungal drugs is prevalent; raising concern that these drugs may no longer be useful for treating moderate or severe fungal infections in West Africa hence calling for countries to promote acceptance of antimicrobial stewardship as a programmatic strategy not just focused on bacterial resistance but also fungal resistance including pharmacy management, laboratory complete mycological investigations and dissemination of standard fungal susceptibility profiles.
- Open Access
- 30 May 2021
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 4 (2) , 145-156
Antibiotic-Resistant Profiles of Bacteria Isolated from Cesarean and Surgical Patients from Kasese District Hospitals Western Uganda
Surgical site infections (SSIs) are challenging to treat and often associated with much higher extended stays, morbidity, and mortality, higher treatment costs, especially when the causative agent is multidrug resistance (MDR). This study was designed to determine the prevalence of nosocomial infections and susceptibility profiles of bacteria isolated from Cesarean section (C-section) and surgical patients from Kasese District Hospitals in Western Uganda. A descriptive cross-sectional study was conducted from January to September 2016 involving 303 patients with SSIs in obstetrics & gynecology; and general surgery wards in three health facilities. Clinical-demographic characteristics of patients were obtained using structured questionnaires before surgery. Bacterial analysis of the air and floor of the theatre room was done using the standard culture method. Of the 303 patients enrolled with SSIs (median age 34 years), 71.6% were female, and 28.4% were males. Only 14.5% developed SSIs, with predominant isolates being Staphylococcus aureus 33.33% and Escherichia coli 24%. The majority of recruited participants underwent a C-section of 58% and the least amputations of 0.3%. Duration of operation or surgery, p-value 0.002 (95% CI 1.599-7.667) was significantly associated with SSIs. Gram-negative bacteria were found resistant (50-100%) to ampicillin, gentamycin, and ciprofloxacin, the commonly used post-operative drugs of choice. Hospital-acquired infections were common with emerging antibiotic-resistant strains isolated in most SSIs at Kasese hospitals. The development of resistance to commonly used antibiotics such as ampicillin, gentamycin, and ciprofloxacin than previously reported calls for laboratory-guided SSIs therapy and strengthening infection control policies.
- 30 May 2021
- Published by Universitas Muhammadiyah Palangkaraya in Borneo Journal of Pharmacy
- Vol. 4 (2) , 145-156
Open AccessAntibiotic-Resistant Profiles of Bacteria Isolated from Cesarean and Surgical Patients from Kasese District Hospitals Western Uganda
Surgical site infections (SSIs) are challenging to treat and often associated with much higher extended stays, morbidity, and mortality, higher treatment costs, especially when the causative agent is multidrug resistance (MDR). This study was designed to determine the prevalence of nosocomial infections and susceptibility profiles of bacteria isolated from Cesarean section (C-section) and surgical patients from Kasese District Hospitals in Western Uganda. A descriptive cross-sectional study was conducted from January to September 2016 involving 303 patients with SSIs in obstetrics & gynecology; and general surgery wards in three health facilities. Clinical-demographic characteristics of patients were obtained using structured questionnaires before surgery. Bacterial analysis of the air and floor of the theatre room was done using the standard culture method. Of the 303 patients enrolled with SSIs (median age 34 years), 71.6% were female, and 28.4% were males. Only 14.5% developed SSIs, with predominant isolates being Staphylococcus aureus 33.33% and Escherichia coli 24%. The majority of recruited participants underwent a C-section of 58% and the least amputations of 0.3%. Duration of operation or surgery, p-value 0.002 (95% CI 1.599-7.667) was significantly associated with SSIs. Gram-negative bacteria were found resistant (50-100%) to ampicillin, gentamycin, and ciprofloxacin, the commonly used post-operative drugs of choice. Hospital-acquired infections were common with emerging antibiotic-resistant strains isolated in most SSIs at Kasese hospitals. The development of resistance to commonly used antibiotics such as ampicillin, gentamycin, and ciprofloxacin than previously reported calls for laboratory-guided SSIs therapy and strengthening infection control policies.